Brief: Advicenne: FDA Grants Orphan Drug Designation To ADV7103 For Treatment Of Cystinuria

Advicenne SA

25/03/2024 06:35

March 25 (Reuters) - Advicenne SA  ALDVI.PA :
    * FDA GRANTS ORPHAN DRUG DESIGNATION TO ADV7103 FOR
TREATMENT OF
CYSTINURIA
    * COMPANY IS NOW LOOKING FORWARD TO SIGNING A PARTNERSHIP TO
PURSUE DEVELOPMENT AND PREPARE MARKETING OF ADV7103 IN U.S IN
ITS TWO INDICATIONS: CYSTINURIA AND DRTA

Source text for Eikon:  ID:nBw3ryspLa 
Further company coverage:  ALDVI.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))